SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Alaunos Therapeutics, Inc. (TCRT) News

Follow Alaunos Therapeutics, Inc. (TCRT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol TCRT Asset equity Sector Markets 90 days 5 Last 1.67 Updated Oct 13, 2026, 06:24 PM UTC Open live news feed Open TCRT chart & news
M Alaunos Acquires Velaris in $350 Million Private Placement Alaunos Therapeutics reported the acquisition of Velaris Therapeutics and a $350 million private placement led by Fairmount. Its shares more than doubled to $2.92. EQUITY | Oct 13, 2026, 06:24 PM UTC L Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics MNA | Oct 13, 2026, 02:38 PM UTC M Alaunos Acquires Velaris in Stock Merger, Secures $350 Million PIPE Alaunos Therapeutics completed a stock-for-stock acquisition of Velaris and signed a $350 million PIPE to fund development of Velaris programs. EQUITY | Oct 13, 2026, 01:34 PM UTC M Paragon Labs adds former Apogee executives; Alaunos acquires Velaris Therapeutics The alert reports leadership-team additions at Paragon Labs and an acquisition of Velaris Therapeutics by Alaunos Therapeutics, Inc. It provides no further details. EQUITY | Oct 13, 2026, 11:00 AM UTC L TCRT - Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules TCRT - Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules NEWS | Sep 18, 2026, 01:00 PM UTC